Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for AKBLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 66.57%
March 31, 2026 69.34%
December 31, 2025 68.09%
September 30, 2025 68.17%
June 30, 2025 65.16%
March 31, 2025 66.75%
December 31, 2024 63.64%
September 30, 2024 64.13%
June 30, 2024 63.10%
March 31, 2024 65.80%
December 31, 2023 62.75%
September 30, 2023 61.71%
June 30, 2023 62.29%
March 31, 2023 64.75%
December 31, 2022 61.73%
September 30, 2022 60.26%
June 30, 2022 61.34%
March 31, 2022 63.98%
December 31, 2021 63.79%
September 30, 2021 60.24%
June 30, 2021 58.29%
March 31, 2021 61.70%
December 31, 2020 58.43%
September 30, 2020 55.44%
June 30, 2020 56.48%
Date Value
March 31, 2020 61.19%
December 31, 2019 58.32%
September 30, 2019 60.35%
June 30, 2019 50.83%
March 31, 2019 61.36%
December 31, 2018 55.15%
September 30, 2018 56.43%
June 30, 2018 53.99%
March 31, 2018 58.51%
December 31, 2017 64.48%
September 30, 2017 57.57%
June 30, 2017 56.87%
March 31, 2017 61.98%
December 31, 2016 65.12%
September 30, 2016 65.40%
June 30, 2016 65.46%
March 31, 2016 70.99%
December 31, 2015 70.45%
September 30, 2015 69.12%
June 30, 2015 61.59%
March 31, 2015 67.69%
December 31, 2014 69.44%
September 30, 2014 64.75%
June 30, 2014 69.76%
March 31, 2014 73.83%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 78.21%
H. Lundbeck A/S 79.00%
AstraZeneca PLC 76.09%
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%

Gross Profit Margin (Quarterly) Related Metrics